Synovial tissue heterogeneity and peripheral blood biomarkers.
about
B cells in rheumatoid arthritis: from pathogenic players to disease biomarkers.Serum levels of CXCL13 are associated with ultrasonographic synovitis and predict power Doppler persistence in early rheumatoid arthritis treated with non-biological disease-modifying anti-rheumatic drugs.Assessment of synovitis to predict bone erosions in rheumatoid arthritis.Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical featuresImmunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission.Advances and challenges in hemophilic arthropathy.Association of systemic and intra-articular osteoclastogenic potential, pro-inflammatory mediators and disease activity with the form of inflammatory arthritis.Inflammatory lesions in the bone marrow of rheumatoid arthritis patients: a morphological perspectiveThe problem of choice: current biologic agents and future prospects in RA.Targeting the programmed cell death-1 pathway in rheumatoid arthritis.Different behavior of myeloperoxidase in two rodent amoebic liver abscess models.Treatment comparison in rheumatoid arthritis: head-to-head trials and innovative study designsThe draining lymph node in rheumatoid arthritis: current concepts and research perspectives.Moving towards personalized medicine in rheumatoid arthritis.The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers.Increased chemotaxis and activity of circulatory myeloid progenitor cells may contribute to enhanced osteoclastogenesis and bone loss in the C57BL/6 mouse model of collagen-induced arthritis.
P2860
Q33616360-5CEA6FDD-EEC1-41B7-B00A-0671C3FCC959Q36085027-E221207C-58F1-4DAA-9450-FB7F412A1C17Q36111299-F6806A7D-AE33-468E-90C2-AB51A8896721Q36245883-55007EEB-2073-41CC-BF36-06FF1DCF8D5FQ36758489-F6F08FD5-9CED-4966-A794-5AF6238637B6Q37279529-BC25AED0-BD63-413F-ACF8-1F2B25D2233AQ37472160-25082A2F-08B4-408C-8886-E199F5CCFF1CQ38070027-C32A7257-8F4A-47C8-913E-703956D924B6Q38082588-9C2C724D-1958-407A-8BCB-8936C13FBDC7Q39344907-C77DEB17-1D2C-41D1-8B65-57E865ECFD95Q41347561-805E6BD4-7435-47FE-AB15-D4EEB11875F8Q41450339-8CB4CFEF-4D57-459B-9FF5-2CFC527F570FQ42181555-3910E6DA-D81B-4894-A17F-219A4957CF25Q42699496-B56519FE-A8B7-44F7-96A7-11401757A8B1Q45928777-FCCD7CA8-3C05-4B85-9FFF-D11BBDB119CDQ48297258-EFC9ACEC-1B1A-4AB7-8806-23B8E48D1F13
P2860
Synovial tissue heterogeneity and peripheral blood biomarkers.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Synovial tissue heterogeneity and peripheral blood biomarkers.
@en
Synovial tissue heterogeneity and peripheral blood biomarkers.
@nl
type
label
Synovial tissue heterogeneity and peripheral blood biomarkers.
@en
Synovial tissue heterogeneity and peripheral blood biomarkers.
@nl
prefLabel
Synovial tissue heterogeneity and peripheral blood biomarkers.
@en
Synovial tissue heterogeneity and peripheral blood biomarkers.
@nl
P2093
P2860
P1476
Synovial tissue heterogeneity and peripheral blood biomarkers
@en
P2093
Antonio Manzo
Barbara Vitolo
Carlomaurizio Montecucco
Frances Humby
Michele Bombardieri
Stephen Kelly
P2860
P2888
P304
P356
10.1007/S11926-011-0201-Y
P577
2011-10-01T00:00:00Z